@article{ff02762164c242e88b457cd3916b46c1,
title = "2017 Infectious Diseases Society of America{\textquoteright}s Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis*",
abstract = "The Infectious Diseases Society of America (IDSA) Standards and Practice Guidelines Committee collaborated with partner organizations to convene a panel of 10 experts on healthcare-associated ventriculitis and meningitis. The panel represented pediatric and adult specialists in the field of infectious diseases and represented other organizations whose members care for patients with healthcare-associated ventriculitis and meningitis (American Academy of Neurology, American Association of Neurological Surgeons, and Neurocritical Care Society). The panel reviewed articles based on literature reviews, review articles and book chapters, evaluated the evidence and drafted recommendations. Questions were reviewed and approved by panel members. Subcategories were included for some questions based on specific populations of patients who may develop healthcare-associated ventriculitis and meningitis after the following procedures or situations: cerebrospinal fluid shunts, cerebrospinal fluid drains, implantation of intrathecal infusion pumps, implantation of deep brain stimulation hardware, and general neurosurgery and head trauma. Recommendations were followed by the strength of the recommendation and the quality of the evidence supporting the recommendation. Many recommendations, however, were based on expert opinion because rigorous clinical data are not available. These guidelines represent a practical and useful approach to assist practicing clinicians in the management of these challenging infections.",
keywords = "central nervous system infections, cerebrospinal fluid drains, cerebrospinal fluid shunts, meningitis, ventriculitis",
author = "Tunkel, \{Allan R.\} and Rodrigo Hasbun and Adarsh Bhimraj and Karin Byers and Kaplan, \{Sheldon L.\} and Scheld, \{W. Michael\} and \{van de Beek\}, Diederik and Bleck, \{Thomas P.\} and Garton, \{Hugh J.L.\} and Zunt, \{Joseph R.\}",
note = "Funding Information: Potential conflicts of interest. The following is a reflection of what has been reported to the IDSA regarding potential conflicts of interest (COI). In order to provide thorough transparency, the IDSA requires full disclosure of all relationships, regardless of relevancy to the guideline topic. Such relationships as potential conflicts of interest are determined by a review process that includes assessment by the Standards and Practice Guidelines Committee (SPGC) chair, the SPGC liaison to the development panel, and the Board of Directors (BOD) liaison to the SPGC, and, if necessary, the COI Task Force of the Board. This assessment of disclosed relationships for possible COI is based on the relative weight of the financial relationship (ie, monetary amount) and the relevance of the relationship (ie, the degree to which an association might reasonably be interpreted by an independent observer as related to the topic or recommendation of consideration). The reader should be mindful of this when the list of disclosures is reviewed. A. T. received royalties from UpToDate and Elsevier and honoraria from ACP and Merck. A. B. received research support from Cubist. R. H. has received personal fees for speaker bureau participation with Pfizer, Medicine{\textquoteright}s Company and Biofire; he has served as a consultant for Biomeriaux. S. K. served as a consultant for Pfizer; received royalties from UpToDate and Elsevier; and received research grants from Pfizer, Forest Laboratories, Cubist, and Merck. W. M. S. received research grants from the National Institutes of Health, Pfizer, and Wyeth. D. v. d. B received research grants from the Netherlands Organization for Health Research and Development, Netherlands Scientific Organization, European Research Council, FP-7, Horizon 2020, and Omeros and served as a consultant for GSK. All other authors: No reported conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed. Funding Information: The expert panel expresses its gratitude for thoughtful reviews of an earlier version by Drs Naomi O?Grady, Richard Whitley, William E. Whitehead, and Ram Yogev. The panel thanks Vita Washington for her guidance and preparation of the manuscript. Support for these guidelines was provided by the Infectious Diseases Society of America (IDSA). Publisher Copyright: {\textcopyright} The Author 2017.",
year = "2017",
month = mar,
day = "15",
doi = "10.1093/cid/ciw861",
language = "English",
volume = "64",
pages = "701--706",
journal = "Clinical infectious diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "6",
}
SDG 3 Good Health and Well-being